Highlight of 2023: Microglia biology

IF 3.2 4区医学 Q3 CELL BIOLOGY

Immunology & Cell Biology Pub Date : 2024-04-23 DOI:10.1111/imcb.12754

Amy Dashwood, Adrian Liston

引用次数: 0

Abstract

The field of neuroimmunology is quickly expanding and, as the primary immune cell of the brain, microglia are truly in the spotlight. In 2023, the number of microglia related articles published on PubMed rose to 5152. This number has consistently increased year on year and has more than doubled since 2013, as we begin to appreciate the role of microglia in brain development, health and disease. The year 2023 continued to bring new important discoveries, extending our knowledge of microglia biology. This image was created in BioRender.com.

Abstract Image

查看原文本刊更多论文

2023 年亮点：小胶质细胞生物学

神经免疫学领域正在迅速扩展，而作为大脑的主要免疫细胞，小胶质细胞是真正的焦点。2023 年，PubMed 上发表的与小胶质细胞相关的文章数量增至 5152 篇。随着我们开始认识到小胶质细胞在大脑发育、健康和疾病中的作用，这一数字持续逐年增加，自2013年以来增加了一倍多。2023 年将继续带来新的重要发现，扩展我们对小胶质细胞生物学的认识。本图片由 BioRender.com 制作。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Immunology & Cell Biology 医学-免疫学

CiteScore

7.50

自引率

2.50%

发文量

审稿时长

4-8 weeks

期刊介绍： The Australasian Society for Immunology Incorporated (ASI) was created by the amalgamation in 1991 of the Australian Society for Immunology, formed in 1970, and the New Zealand Society for Immunology, formed in 1975. The aim of the Society is to encourage and support the discipline of immunology in the Australasian region. It is a broadly based Society, embracing clinical and experimental, cellular and molecular immunology in humans and animals. The Society provides a network for the exchange of information and for collaboration within Australia, New Zealand and overseas. ASI members have been prominent in advancing biological and medical research worldwide. We seek to encourage the study of immunology in Australia and New Zealand and are active in introducing young scientists to the discipline.